Utama › Kanser Darah › Alabama › Birmingham
Kajian klinikal Kanser Darah di Birmingham, AL
11 kajian untuk Kanser Darah sedang mencari peserta di lokasi dalam dan sekitar Birmingham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 2
- University of Alabama Birmingham, Birmingham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 16, Birmingham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Mengambil pesertaFasa 1/2
- O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- University of Alabama at Birmingham, Birmingham
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Mengambil pesertaFasa 3
- Children's Hospital of Alabama, Birmingham
Cognitive Training Intervention and Attitudes Towards Genetics
Mengambil peserta
- University of Alabama at Birmingham, Birmingham
UAB 2419-CD34 Selection Using the Automated CliniMACS Prodigy
Mengambil pesertaFasa 1
- University of Alabama at Birmingham, Birmingham
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
Mengambil pesertaFasa 1
- University of Alabama at Birmingham, Birmingham
Diet and Cognitive Training in Hematologic Cancer Survivors
Mengambil peserta
- University of Alabama at Birmingham, Birmingham
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Mengambil peserta
- University of Alabama at Brimingham, Birmingham
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Mengambil pesertaFasa 1
- University of Alabama at Birmingham, Birmingham
Kajian Kanser Darah di bandar lain
- Houston, TX46 kajian
- New York City, NY26 kajian
- Boston, MA25 kajian
- Washington, DC19 kajian
- Baltimore, MD18 kajian
- Seattle, WA18 kajian
- Los Angeles, CA17 kajian
- Durham, NC16 kajian
- Chicago, IL15 kajian
- Philadelphia, PA14 kajian
- Atlanta, GA13 kajian
- Nashville, TN13 kajian
Kajian lain di Birmingham
- Kanser (semua jenis)30 kajian
- Kanser Payudara24 kajian
- Obesiti23 kajian
- Kanser Ovari23 kajian
- Kanser Paru-paru Bukan Sel Kecil22 kajian
- Leukemia Mieloid Akut21 kajian
- Mieloma Pelbagai18 kajian
- COPD17 kajian
- Penyakit Kardiovaskular17 kajian
- Berat Badan Berlebihan16 kajian
- Kanser Endometrium16 kajian
- Diabetes Jenis 216 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.